Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in TRDA — Entrada Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in TRDA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$256,375
+$98,464 QoQ
Shares Held
20,315
+32.3% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRDA Over Time

Shares Held

Position Value (USD)

Derivatives in TRDA

reported options exposure · as of Mar 31, 2026
CallValue
$291,522
CallShares
23,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TRDA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $256,375 20,315
2026-03-31 $291,522 23,100
2025-12-31 $157,911 15,361
2025-12-31 $228,216 22,200
2025-09-30 $81,200 14,000
2025-09-30 $79,460 13,700
2025-09-30 $66,746 11,508
2025-06-30 $105,504 15,700
2025-06-30 $247,396 36,815
2025-03-31 $288,918 31,960
2024-12-31 $223,594 12,932
2024-12-31 $548,093 31,700
2024-09-30 $180,574 11,300
2024-09-30 $474,606 29,700
2023-03-31 $2,849,438 196,513
2022-12-31 $1,511,495 111,797